GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE199653 Query DataSets for GSE199653
Status Public on Apr 01, 2022
Title Hepatitis B virus core protein is not required for cccDNA transcriptional regulation
Organisms Homo sapiens; Hepatitis B virus
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Background & Aims: Hepatitis B virus (HBV) infection is a major health burden worldwide and currently there is no cure. The persistence of HBV covalently closed circular DNA (cccDNA) is the major obstacle for antiviral treatment. HBV core protein (HBc) has merged as a promising antiviral target, as it plays important roles in critical steps of viral life cycle. However, whether HBc could regulate HBV cccDNA transcription remains to be illustrated.
Methods: Synthesized HBV cccDNA and HBVcircle with or without HBc deficiency were transfected into hepatocytes. A recently reported Adeno-Associated Virus (AAV) mediated HBV cccDNA mouse model was employed. Two capsid assembly modulators (CAMs) were used. HBV replication markers were evaluated. Chromatin immunoprecipitation (ChIP) or ChIP sequencing assays were conducted with different transcription factors, histones and RNA polymerase 2.
Results: In HBV cccDNA and HBVcircle transfection assays, lack of HBc showed no effect on transcription of HBV RNA as well as HBV surface antigen production. Reconstitution of HBc did not change cccDNA derived HBV markers. Similar results were obtained in vivo, from mouse cccDNA model. ChIP data revealed similar transcription regulation of HBc deficient cccDNA chromatin with wide type cccDNA. Furthermore, CAMs treatment could not alter cccDNA transcription.
Conclusions: Our results indicate that HBc neither affects histone modifications and transcription factors binding of cccDNA, nor influences cccDNA transcription. Although CAMs could reduce HBc binding to cccDNA, it does not suppress cccDNA transcriptional activity. Thus, therapeutic targeting capsid or HBc is not sufficient to reduce cccDNA transcription.
Overall design eight samples were analyzed
Web link
Contributor(s) Xia Y, Zhong Y, Wang W, Wu C
Citation(s) 36226986
Submission date Mar 29, 2022
Last update date Mar 08, 2023
Contact name Youquan Zhong
Organization name Wuhan University
Department TaiKang Medical School,
Lab XIA lab
Street address NO.115, Donghu road, Wuchang district, Wuhan city, Hubei province, China.
City Wuhan
State/province hubei
ZIP/Postal code 430000
Country China
Platforms (1)
GPL32090 Illumina NovaSeq 6000 (Hepatitis B virus; Homo sapiens)
Samples (8)
GSM5979888 1-1
GSM5979889 1-2
GSM5979890 2-1
BioProject PRJNA821068

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE199653_RAW.tar 50.0 Kb (http)(custom) TAR (of BW)
GSE199653_reference_sequence.txt.gz 1.1 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap